Introduction
Symptoms of asthma, chronic rhinitis, urticaria, and angioncurotic oedema may occur in patients who arc allergic to aspirin (Van Lecuwen, 1924; Bruce Pearson, 1963 ; Samter and Becrs, 1968) . These symptoms rarely occur in the same patient, and more usually asthma, rhinitis, and urticaria are seen separately. Classically, the syndrome first presents in the third or fourth decade of life with watery nasal discharge, and later with nasal polypi. After a variable interval from weeks to years, bronchial asthma is first noticed, often being precipitated by nasal polypectomy or by aspirin ingestion. Thereafter the patient experiences persistent wheezing with severe, even life-thrcatening, attacks of asthma after taking aspirin. Avoiding aspirin, however, does not abolish the asthma, which is usually wcll controlled by small regular doses of corticosteroids.
In addition to aspirin, other drugs or chemicals may precipitate attacks of asthma in patients who suffer from this condition. These include alcohol, indomethacin, amidopyrine, and tartrazine (Samter and Beers, 1968) , the latter being a ycllow colouring material commonly found in soft drinks, canncd vegetables, and many other foodstuffs. This paper presents the results of air-flow measuremcnts on fivc aspirin-sensitive patients challenged by some other commonly used analgesics. Samter and Beers (1968) 
Results
The changcs in FEV1 arc prcsented in the Chart and the percentage maximum changes in FEV1 for each drug in Table II . In no patient did the control preparation cause a change in FEV1 of more than 10',(, nor was rhinitis or wheezing induced.
The association of rhinitis with each analgesic challenge is presented in Table III . This symptom was seen after challenge with paracetamol, indomethacin, and mefenamic acid; no patient complained of rhinitis after dextropropoxyphene or phenylbutazone. It will be noted that the most severe wheeze and the most severe rhinitis were not always seen together in the same patient; indeed, the patient with the most severe rhinitis (Case 5) had the least FEV, response to all the drugs.
Similarly, a drug causing rhinitis in one patient would be associated with wheezing in another. (Cases 1-3) . The association of indomethacin with attacks of wheezing in aspirin-allergic subjects has been described by Vaneslow and Smith (1967) and Samter and Beers (1968) . Paracetamol, mefenamic acid, and dextropropoxyphene, however, have not been regarded as harmful to these patients in the past. It is of interest to note at this point that Brocks (1967) Pearson, 1963) , amidopyrine and phenazone (Herxheimer and Stresemann, 1961) , phenylbutazone (Von Rechenberg, 1962) , and mefenamic acid (Jackson, Raymer, and Etter, 1968) to be of value in the treatment of asthma. Corier et al. Shorley, 1960, 1963; Collier, James, and Schneider, 1966; Collier, James, and Piper, 1968) Samter and Beers (1967) , in their extensive review of this subject, suggested that the cause of aspirin allergy lies in an alteration of bronchial and nasal nociceptors. Their hypothesis suggests that normal receptors, normally protected from kinin stimulation by aspirin, are so altered by a pre-existing disease process that they are stimulated rather than protected by aspirin. This concept rests on the assumption that the theory advanced by Paton (1961 Paton ( , 1967 (Giraldo, Blumenthal, and Spink, 1969; Girard, Hildebrant, and Favre, 1969) . Giraldo et al. review the literature and conclude that there is no satisfactory evidence that immunological factors are involved in aspirin allergy. The wide variation in molecular structure of the drugs which produce a similar reaction tends to reinforce this view. Indeed, we recommend that the term "aspirin allergy" be abandoned altogether in this context, and a term such as "analgesic-induced asthma syndrome" be substituted until the cause of the disease is understood.
In terms of practical medicine this investigation underlines the importance of great caution in prescribing analgesic drugs to patients thought to be sensitive to aspirin. Exacerbations of asthma or an increase in steroid requirement in patients with a painful condition requiring analgesics should be evaluated in the light of the knowledge that such drugs may cause severe bronchoconstriction. In cases of doubt it is justifiable to perform cautious analgesic challenge tests, though this procedure is not recommended in the case of aspirin itself as challenge with even minute doses of this drug may result in a life-threatening reaction; this is not likely to happen with other analgesics.
